72 related articles for article (PubMed ID: 20015626)
1. Coordination to gallium(III) strongly enhances the potency of 2-pyridineformamide thiosemicarbazones against Cryptococcus opportunistic fungi.
Bastos Tde O; Soares BM; Cisalpino PS; Mendes IC; dos Santos RG; Beraldo H
Microbiol Res; 2010 Sep; 165(7):573-7. PubMed ID: 20015626
[TBL] [Abstract][Full Text] [Related]
2. Gallium(III) complexes of 2-pyridineformamide thiosemicarbazones: cytotoxic activity against malignant glioblastoma.
Mendes IC; Soares MA; Dos Santos RG; Pinheiro C; Beraldo H
Eur J Med Chem; 2009 May; 44(5):1870-7. PubMed ID: 19070402
[TBL] [Abstract][Full Text] [Related]
3. Ciclopirox olamine: an antifungal alternative against cryptococcosis.
Oliveira PC; Medeiros CS; Macêdo DP; Andrade SL; Correia MT; Mesquita SD; Lima-Neto RG; Neves RP
Lett Appl Microbiol; 2010 Nov; 51(5):485-9. PubMed ID: 21039663
[TBL] [Abstract][Full Text] [Related]
4. Gallium(III) complexes with 2-acetylpyridine-derived thiosemicarbazones: antimicrobial and cytotoxic effects and investigation on the interactions with tubulin.
Lessa JA; Soares MA; dos Santos RG; Mendes IC; Salum LB; Daghestani HN; Andricopulo AD; Day BW; Vogt A; Beraldo H
Biometals; 2013 Feb; 26(1):151-65. PubMed ID: 23344786
[TBL] [Abstract][Full Text] [Related]
5. 2-Pyridineformamide N(4)-ring incorporated thiosemicarbazones inhibit MCF-7 cells by inhibiting JNK pathway.
Shakya B; Shahi N; Ahmad F; Yadav PN; Pokharel YR
Bioorg Med Chem Lett; 2019 Jul; 29(13):1677-1681. PubMed ID: 31053506
[TBL] [Abstract][Full Text] [Related]
6. Organotin(IV) complexes of 2-pyridineformamide-derived thiosemicarbazones: antimicrobial and cytotoxic effects.
Mendes IC; Moreira JP; Ardisson JD; Santos RG; da Silva PR; Garcia I; Castiñeiras A; Beraldo H
Eur J Med Chem; 2008 Jul; 43(7):1454-61. PubMed ID: 17983689
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity.
Opletalová V; Kalinowski DS; Vejsová M; Kunes J; Pour M; Jampílek J; Buchta V; Richardson DR
Chem Res Toxicol; 2008 Sep; 21(9):1878-89. PubMed ID: 18698850
[TBL] [Abstract][Full Text] [Related]
8. Copper complexes of imidazole-2-, pyrrole-2- and indol-3-carbaldehyde thiosemicarbazones: inhibitory activity against fungi and bacteria.
Rodríguez-Argüelles MC; López-Silva EC; Sanmartín J; Pelagatti P; Zani F
J Inorg Biochem; 2005 Nov; 99(11):2231-9. PubMed ID: 16188319
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 2-pyridineformamide thiosemicarbazones as potent antiausterity agents.
Shakya B; Yadav PN; Ueda JY; Awale S
Bioorg Med Chem Lett; 2014 Jan; 24(2):458-61. PubMed ID: 24380769
[TBL] [Abstract][Full Text] [Related]
10. Antifungal and antibacterial activity of 2-acetylpyridine-(4-phenylthiosemicarbazone) and its metal (II) complexes.
Offiong OE; Martelli S
Farmaco; 1992 Dec; 47(12):1543-54. PubMed ID: 1294169
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H
Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antibacterial and antifungal activity of metal (II) complexes of 2-acetylpyridine thiosemicarbazones.
Offiong OE; Martelli S
Farmaco; 1993 Jun; 48(6):777-93. PubMed ID: 8373503
[TBL] [Abstract][Full Text] [Related]
13. Determination of antifungal activity of polyenzyme preparation Candidaseb using in vitro methods.
Joshi A; Deshpande S; Dohe V; Risbud S; Bharadwaj R
Hindustan Antibiot Bull; 2007 Feb-2008 Nov; 49-50(1-4):10-3. PubMed ID: 19957538
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of ambroxol on Cryptococcus adherence, planktonic cells, and biofilms.
Kong Q; Du X; Huang S; Yang R; Zhang C; Shen Y; Liu W; Sang H
APMIS; 2017 Jul; 125(7):634-640. PubMed ID: 28444776
[TBL] [Abstract][Full Text] [Related]
15. In vitro sensitivity of human and environmental strains of Crytococcus neoformans to micronized hamycin.
Padhye AA
Sabouraudia; 1969 Oct; 7(3):182-5. PubMed ID: 5394059
[No Abstract] [Full Text] [Related]
16. Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans.
Perkins A; Gomez-Lopez A; Mellado E; Rodriguez-Tudela JL; Cuenca-Estrella M
J Antimicrob Chemother; 2005 Dec; 56(6):1144-7. PubMed ID: 16282208
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome.
Poon M; Cronin DC; Wormser GP; Bottone EJ
Arch Pathol Lab Med; 1988 Feb; 112(2):161-2. PubMed ID: 3276290
[TBL] [Abstract][Full Text] [Related]
18. In vitro antifungal activity of polyfunctionalized 2-(hetero)arylquinolines prepared through imino Diels-Alder reactions.
Meléndez Gómez CM; Kouznetsov VV; Sortino MA; Alvarez SL; Zacchino SA
Bioorg Med Chem; 2008 Sep; 16(17):7908-20. PubMed ID: 18752959
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of clinical isolates of Cryptococcus neoformans to amphotericin B using time-kill methodology.
Pappalardo MC; Szeszs MW; Martins MA; Baceti LB; Bonfietti LX; Purisco SU; Baez AA; Melhem MS
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):146-51. PubMed ID: 19345042
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of novel metal complexes of 2-acetylpyridine thiosemicarbazones.
Offiong OE; Martelli S
Farmaco; 1995 Sep; 50(9):625-32. PubMed ID: 7495474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
